1. Pedersen, S. S. Lung infection with alginate-producing, mucoidPseudomonas aeruginosa in cystic fibrosis. APMIS 100 (Suppl. 28) (1992) 7–79.
2. Pressler, T., Pedersen, S. S., Espersen, F., Høiby, N., Koch, C. IgG subclass antibodies toPseudomonas aeruginosa in sera from patients with chronicPs. aeruginosa infection investigated by ELISA. Clin. Exp. Immunol. 81 (1990) 428–434.
3. Moss, R. B., Hsu, Y-P., Lewiston, N. J., Curd, J. G., Milgrom, H., Hart, S., Dyer, B., Larrick, J. W. Association of systemic immune complexes, complement activation, and antibodies toPseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis. Am. Rev. Respir. Dis. 133 (1986) 648–652.
4. Fomsgaard, A., Dinesen, B., Shand, G. H., Pressler, T., Høiby, N. Antilipopolysaccharide antibodies and differential diagnosis of chronicPseudomonas aeruginosa lung infection in cystic fibrosis. J. Clin. Microbiol. 27 (1989) 1222–1229.
5. Kronborg, G., Fomsgaard, A., Galanos, C., Freudenberg, M. A., Høiby, N. Antibody responses to lipid A, core, and O sugars of thePseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. J. Clin. Microbiol. 30 (1992) 1848–1855.